Atugen Raises 5M for Developing siRNA Therapeutics

Mar 15, 2004

NEW YORK, March 15 (GenomeWeb News) - RNAi firm Atugen has raised €5 million in a third financing round, the company said today.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.